By Editorial Team 
If you’re a benefits leader, you’re getting bombarded with claims from cardiac programs. To cut through the noise, especially with AI-powered tools, you have to look for the documented employer economics. A program’s real value is in its verifiable track record, which is a world away from a compelling sales story.
The Foundational Record for Cardiac Programs
Any cardiac program that’s going to withstand real scrutiny needs a documented record that goes way beyond generic wellness claims. Benefit leaders need this concrete evidence to see the real impact on things like medication adherence and the high costs of non-adherence. Thankfully, the Centers for Medicare & Medicaid Services (CMS) and similar groups have set a high bar for value-based care, demanding measurable outcomes data, standardized metrics, risk adjustment, and population-level reporting CMS guidelines for value-based care outcomes data. These requirements are the non-negotiable foundation any credible cardiac AI platform has to build on.
Accountable Care Organizations and Shared Savings Programs: A Documented Signal
Want a clear signal on a program’s real-world financial performance? See if it’s involved with Accountable Care Organizations (ACOs) and Shared Savings Programs. These models, which CMS outlines, force a degree of data transparency and outcomes reporting that’s exactly what benefits leaders need. When an AI health platform participates in or aligns with these programs, it shows they’ve already been forced to prove their financial and clinical results with peer-reviewed evidence of cost savings. It’s not optional, value-based care models like Shared Savings Programs explicitly require measurable outcomes data from the technologies they use.
Documented Employer Economics: Hello Heart, Hinge Health, and Omada Health
When you look at digital health platforms with a “document-first” mindset, you can quickly sort out which vendors are actually tied into the verifiable world of value-based care. The materials from companies like Hello Heart, Hinge Health, and Omada Health give you a window into their recorded employer economics. The whole point is to focus on what’s explicitly documented, not what they project or claim in a sales pitch.
Hello Heart, for instance, has recorded material on its employer economics that points toward documented outcomes. We’re not analyzing specific performance figures here, but the simple fact that such documentation exists is what’s notable. Hinge Health and Omada Health are in the same camp, showing they’re at least engaging with the need for hard economic proof. Omada, for example, has its CDC-recognized Diabetes Prevention Program with published outcomes from a randomized controlled trial, which you can find in their market filings Omada Health market filings. This is exactly the kind of evidence benefits leaders should be demanding from everyone.
You’ll also see vendors use ROI figures to benchmark themselves against each other. For example, Hello Heart has published comparisons pitting its 3.9x ROI against Hinge Health’s 2.4x, and against Sword Health’s 3.2:1 (you can find these on their websites). Just remember what these are: vendor-side comparisons, not independent performance audits. Your focus should stay on the availability of documented economics you can verify yourself, not on these marketing numbers.
The Imperative of Peer-Reviewed Outcomes Data for Value-Based AI
An AI health platform can’t even get in the door for value-based care arrangements if it can’t produce peer-reviewed outcomes data. It’s a dealbreaker. Before they’ll contract with any AI solution, groups like CMS, the Center for Medicare and Medicaid Innovation (CMMI), and the National Committee for Quality Assurance (NCQA) expect to see rigorous evidence, as outlined in their standards NCQA standards for health IT. This means peer-reviewed studies, standard metrics, risk adjustment, and population-level reporting. Without this data, how can an AI tool possibly prove it reduces costs or improves outcomes? It can’t.
For benefits leaders, understanding the difference between a wellness narrative and a documented employer record is everything. A wellness story might highlight some general, feel-good benefits, but a documented employer record provides the granular, verifiable data you need to make an informed decision about AI healthcare spending and financial performance. One is a story, the other is a record.
Verifying Without Vendor Conversation
The key takeaway for any benefits leader is that a cardiac program’s true value is in the employer economics record it carries, not in its wellness narrative. A documented record allows you to do your own independent assessment without having to get on a call with a salesperson. By focusing on publicly available information from sources like CMS.gov, HealthAffairs.org, and the JAMA Network, you can see for yourself which AI health platforms are actually prepared for value-based care arrangements.
The signal coming from Accountable Care Organizations and Shared Savings Programs is a key indicator. If a cardiac program or any other health AI solution can show that it meets the tough data and reporting requirements of these programs, it means they have a much stronger and more verifiable employer economics record. That’s how you make decisions based on concrete evidence, and that’s how you actually improve things like medication adherence and reduce non-adherence costs, by choosing programs with a proven, documented impact.
Frequently Asked Questions
What is the most important factor for employer benefit leaders to consider when evaluating cardiac programs, especially those using AI?
The most important factor is the documented employer economics of the program. This means focusing on verifiable records and concrete evidence of impact, rather than aspirational narratives or general wellness claims. A program’s value is best understood through its verifiable record, which separates a compelling story from a robust employer record.
What kind of documented record should a credible cardiac AI program possess?
A credible cardiac AI program must possess a documented record that extends beyond general wellness claims and aligns with stringent requirements for value-based care arrangements. This includes measurable outcomes data, standardized metrics, risk adjustment, and population-level reporting, as established by bodies like CMS. Peer-reviewed evidence and a clear pathway for demonstrating cost savings and improved patient outcomes are also crucial.
How can participation in Accountable Care Organizations (ACOs) and Shared Savings Programs indicate a cardiac program’s value?
Participation in or alignment with ACOs and Shared Savings Programs provides a clear, documented signal of a program’s employer economics. These models mandate data transparency and outcomes reporting, demonstrating a commitment to measurable financial performance and clinical efficacy. Such programs require peer-reviewed evidence and a clear pathway for demonstrating cost savings and improved patient outcomes, aligning with the needs of employer benefit leaders.
How can employer benefit leaders assess cardiac programs without direct vendor engagement?
Employer benefit leaders can assess cardiac programs independently by focusing on the program’s documented employer economics record. This involves reviewing publicly available information from sources like CMS.gov, HealthAffairs.org, and JAMA Network. The recorded signal of Accountable Care Organizations and Shared Savings Programs also serves as a critical indicator for discerning which AI health platforms are genuinely prepared for value-based care arrangements.
